Lloyd Price

OCTOBER 14, 2024

Investment Strategy: The investment landscape for healthcare startups and emerging technologies. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Health Policy: The impact of healthcare policy on patient outcomes and access to care.

Leadership 56

Leadership healthcare technology Digital Health Mental health 56

Health Populi

APRIL 29, 2019

The bar chart from research by Market Strategies shows that a plurality of consumers also trusts Amazon to try on for healthcare products and services. The Amazon Prime-ing of the U.S. ” People trust Amazon for daily retail experiences. The company has been multi-tasking a broad range of tactics throughout the health care ecosystem.

HIPAA 307

HIPAA Drug Development Digital Health Mental health 307

Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!

Interoperability 72

Interoperability healthcare technology HIPAA Leadership 72

Lloyd Price

DECEMBER 2, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

Mental health 63

Mental health Digital Health healthcare technology Telehealth 63

FierceHealthIT

MARCH 22, 2018

The study’s authors urge policymakers to support the development of new strategies to prevent infections and to support innovative antibiotic drug development. Multiply that by the estimated number of antibiotic-resistant infections, and costs run well over $2 billion per year.

Drug Development 97

Drug Development 97

Lloyd Price

FEBRUARY 9, 2025

By keeping an eye on these developments, you'll be well-positioned to understand the transformative impact of cognitive architecture on the future of healthcare. link] #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #Innovation #NHS #VentureCapital #PrivateEquity #UK #Europe

healthcare technology 69

healthcare technology Mental health Drug Development Interoperability 69

Healthcare IT Today

DECEMBER 6, 2024

In total, Aignostics has now raised over $55 million , reflecting investors’ confidence in its differentiated AI models and clear commercial strategy. “At its core, Aignostics is a world-class machine learning company,” said Julian Zachmann at ATHOS.

Life Science 77

Life Science Drug Development Health IT Healthcare IT 77

Society for Participatory Medicine

FEBRUARY 1, 2023

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.

BioTech 112

BioTech Drug Development Meaningful Use Pharmaceuticals 112

Lloyd Price

JANUARY 20, 2025

Visit [link] Buy Side, Sell Side, Growth & Strategy services for HealthTech Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk Nelson Advisors Healthcare Technology Newsletter > Mergers, Acquisitions, Growth, Strategy, Insights & Predictions. Subscribe Today! Subscribe Today!

Mental health 60

Mental health healthcare technology Telehealth Digital Health 60

Lloyd Price

NOVEMBER 8, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

Digital Health 52

Digital Health healthcare technology Pharmaceuticals Telehealth 52

Lloyd Price

FEBRUARY 7, 2025

Nelson Advisors Healthcare Technology > Mergers, Acquisitions, Growth, Strategy, Investments [link] We work with Healthcare Technology founders, owners and investors to assess whether they should 'Build, Buy, Partner, Invest or Sell' in order to maximise shareholder value and investment returns. Subscribe Today!

healthcare technology 69

healthcare technology Leadership Drug Development Pharmaceuticals 69

Redox

SEPTEMBER 26, 2023

Don’t get so immersed in system processing that you overlook data quality and accessibility, says Deloitte’s Cloud Strategy Officer. Read more Patient engagement Pharma falls short of patient-centricity Experts say orphan drug developers need tech infrastructure, policies, and procedures to overcome patients’ distrust.

FHIR 105

FHIR Drug Development Telehealth Digital Health 105

Lloyd Price

DECEMBER 2, 2024

The increasing prevalence of these conditions is driving demand for innovative solutions and improved management strategies. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today! Subscribe Today!

Digital Health 56

Digital Health healthcare technology Telemedicine Leadership 56

Digital Health Global

NOVEMBER 30, 2023

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Lloyd Price

JUNE 17, 2023

As the ability to collect and analyze large amounts of patient data grows, there is a growing opportunity for companies to develop personalized treatments and care plans. This could lead to mergers between companies that specialize in different aspects of personalized medicine, such as data analytics, genomics, and drug development.

Digital Health 80

Digital Health Drug Development Telemedicine Telehealth 80

Digital Health Global

JANUARY 25, 2024

Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development 88

Drug Development Digital Health 88

Digital Health Global

JUNE 13, 2023

We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights. “The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Digital Health Global

APRIL 25, 2024

About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. Koneksa aims to revolutionize treatment effect detection in clinical research and improve patient outcomes.

Health Data 88

Health Data BioTech Drug Development healthcare technology 88

Healthcare IT Today

NOVEMBER 1, 2022

The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology. In conjunction, COTA announced it has raised additional capital from existing investors. COTA Adds Emerging Types of Data to Oncology Real-World Data Platform.

Life Science 105

Life Science Drug Development Digital Health Health IT 105

Healthcare IT Today

JANUARY 8, 2024

Now, they have new tools such as artificial intelligence (AI) and machine learning (ML) that they can leverage to automatically scour medical literature for information to assist signal evaluation and medical review, or real-world-evidence insights that can lead to drug-safety improvements. Dave Latshaw, CEO at BioPhy 1.

Health IT 93

Health IT Drug Development Pharmaceuticals BioTech 93

Xealth

JUNE 27, 2023

Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Don’t wait until you have a “fully-baked” digital health strategy to begin weighing the pros and cons of DTx implementation.

Digital Health 52

Digital Health Drug Development Pharmaceuticals Nursing 52

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Lloyd Price

NOVEMBER 21, 2023

Exec Summary: To win the hearts and minds of the public in England and successfully deliver the NHS Federated Data Platform (FDP), Palantir should focus on the following strategies: Address Privacy Concerns: Public trust is paramount, particularly when dealing with sensitive patient data. Email lloyd@nelsonadvisors.co.uk Subscribe Today!

Drug Development 69

Drug Development Health science healthcare technology Leadership 69

Lloyd Price

AUGUST 3, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

Mental health 69

Mental health Pain management Drug Development Leadership 69

Healthcare IT Today

JANUARY 22, 2025

Katherine Seay, Executive Vice President at Clinical Trial Media Diversity in healthcare needs to extend to every corner of the industry, from healthcare practitioners to the drug development and discovery process. One area where the need for diversity has never been greater is clinical trials.

EHR 82

EHR Drug Development Remote care Interoperability 82

Digital Health Global

AUGUST 22, 2024

Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia. Cees Wortel, Ph.D., After earning his M.D.

Leadership 88

Leadership Pharmaceuticals Drug Development Digital Health 88

Digital Health Global

NOVEMBER 20, 2023

We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.”

Life Science 88

Life Science Drug Development Digital Health Patient Experience 88

Lloyd Price

MAY 2, 2024

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. To support their strategy, Nvidia recently acquired both Deci and Run AI, making a significant move in the AI landscape.

healthcare technology 72

healthcare technology Drug Development Leadership Digital Health 72

Lloyd Price

MAY 30, 2024

As AI technology becomes more integrated into medical practices, healthcare organisations are looking for leaders to develop strategy and implementation, effectively communicate the benefits and risks of AI to all stakeholders and oversee the development and use of AI to ensure it is fair, unbiased, and adheres to patient privacy regulation.

Leadership 72

Leadership healthcare technology Interoperability Drug Development 72

Healthcare IT Today

MAY 22, 2023

.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.

Life Science 69

Life Science Drug Development Health IT Healthcare IT 69

Healthcare IT News - Telehealth

JANUARY 20, 2022

As work-from-home technology continues to improve, we expect a positive impact on the research and development side for life sciences organizations. Decentralization in life sciences works across all aspects of the drug development life cycle from R&D, regulatory, clinical drug trials, to manufacturing and GTM strategies.

Life Science 203

Life Science Primary Care Mental health Drug Development 203

Digital Health Global

MAY 29, 2024

“Masimo’s SET ® pulse oximetry is sensitive enough to capture key vitals on the very ill like cancer patients, plus it works on all skin tones, all ages, and is easy to use,” said Musaddiq Khan, Medable’s Vice President of Digital Outcomes and TA Strategy. Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Drug Development 88

Drug Development Digital Health 88

Lloyd Price

SEPTEMBER 16, 2024

Biopharma Innovation and Drug Development: The development of innovative drugs and therapies remains a key focus in the healthcare industry. Conference attendees discussed the latest trends in biopharma innovation, including gene therapy, cell therapy, and antibody-drug conjugates. Subscribe Today!

Digital Health 63

Digital Health Drug Development healthcare technology Leadership 63

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. By using this technology in innovative ways, healthcare organisations can improve patient care, reduce costs, and accelerate the development of new treatments. Visit www.nelsonadvisors.co.uk Subscribe Today!

healthcare technology 72

healthcare technology Leadership Drug Development Digital Health 72

Digital Health Global

JUNE 2, 2024

” Mark Slaughter , Chief Strategy & Growth Officer at Mika Health, added, “As cancer treatments become more sophisticated and personalized, patients are increasingly unable to identify and access the targeted therapy and psycho-oncological support they need.

Drug Development 88

Drug Development Pharmaceuticals Mental health Patient Experience 88

Digital Health Global

JANUARY 4, 2024

Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster. Koneksa aims to revolutionize treatment effect detection in clinical research and improve patient outcomes.

Health Technology 88

Health Technology Digital Health Drug Development healthcare technology 88